Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease (NCT05919511)
A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Who can join: Review the eligibility criteria below.
Location: University of Alabama Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
- Non-Interventional (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (32 Sites)
Showing the first 25 of 32 sites.
- University of Alabama Birmingham — Birmingham, Alabama
- Mayo Clinic Arizona — Phoenix, Arizona
- City of Hope — Duarte, California
- USC Norris Comprehensive Cancer Center — Los Angeles, California
- University of Colorado — Aurora, Colorado
- Mayo Clinic Jacksonville — Jacksonville, Florida
- AdventHealth Orlando — Orlando, Florida
- Moffit Cancer Center — Orlando, Florida
- Emory University — Atlanta, Georgia
- Georgia Cancer Center — Augusta, Georgia
- Northwestern University — Chicago, Illinois
- Rush University Medical Group — Chicago, Illinois
- The University of Chicago — Chicago, Illinois
- Loyola University Medical Center — Maywood, Illinois
- The University of Kansas Clinical Research Center — Fairway, Kansas
- Tulane Cancer Center — New Orleans, Louisiana
- University of Maryland Medical Center — Baltimore, Maryland
- Massachusetts Cancer Research Center — Boston, Massachusetts
- Corewell Health — Grand Rapids, Michigan
- Mayo Clinic Rochester — Rochester, Minnesota
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
- Memorial Sloan Kettering Cancer Center — New York, New York
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
- Levine Cancer Institute — Charlotte, North Carolina
- The Ohio State University — Columbus, Ohio
📞 Contact the Study Coordinator
Phone: (855) 463-3463
Email: medinfo@incyte.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in cGVHD
Explore by condition: All cGVHD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.